Seventeen research firms covering NuScale Power Corporation have issued a consensus recommendation of “Reduce,” according to Marketbeat.com. Of those firms, five analysts rate the stock as a sell, eight have held their rating at neutral, and four maintain a buy recommendation. The average 12-month price target across all reports stands at $35.18, reflecting broad skepticism about near-term upside despite the company’s pioneering position in small modular nuclear reactors.

Several high-profile brokerages have adjusted their views over the past quarter. On October 21, BNP Paribas cut its rating from hold to strong sell. Bank of America reiterated an underperform rating on September 30 but reduced its price target from $38.00 to $34.00. Canaccord Genuity, in contrast, boosted its target from $44.00 to $60.00 and maintained a buy stance on September 3. Royal Bank of Canada lowered its target from $35.00 to $32.00 and kept a sector-perform rating on November 10, while Wall Street Zen downgraded the stock from hold to sell on November 8.

In its November 6 earnings release, NuScale reported a loss per share of $1.85, missing the consensus estimate of a $0.11 loss by $1.74. Revenue came in at $8.24 million, below the $11.29 million analysts expected, though this represented a year-over-year surge of 1,635.2%. The company posted a negative return on equity of 51.27% and a net margin of –594.63%. Analysts now forecast a full-year loss per share of $0.73, underscoring continued investment in reactor development at the expense of near-term profitability.

Chief Financial Officer Robert Ramsey Hamady sold 40,000 shares in early December for proceeds of $886,800, reducing his ownership by 46.36% to 46,283 shares. Director Fluor Corporation disposed of 87,900 shares in October, generating $3.48 million. Insiders have collectively sold 3,464,278 shares valued at $139.05 million over the past 90 days, leaving them with just 1.20% of shares outstanding. Meanwhile, institutional investors hold 78.37% of the company. Notable moves include Harbour Investments raising its stake by 21.3% in Q2 to 1,156 shares ($46,000), D.A. Davidson & Co. adding 212 shares to reach 20,822 ($824,000), Pasadena Private Wealth increasing to 6,147 shares ($221,000), Family Capital Management to 8,682 ($313,000), and CIBC World Market to 9,000 shares ($324,000).